High-throughput sperm selection system shows promising results for low motility cases

FHS
August 9, 2024
11:46 pm

An advanced sperm selection system for men experiencing sperm with low motility has been announced by scientists at City University of Hong Kong (CityUHK).

argenx enrols new cohort in Phase II multifocal motor neuropathy study – Pharmaceutical Technology

Immune globulin treatments are the only available MMN therapies – but ARGX-117 could change that. Source: Shutterstock / Kateryna Kon. Netherlands-based immunology company Argenx has

June 20, 2023

Pediatric Allergic March Supported by Nationwide EHR Data

A typical allergic march started with atopic dermatitis during infancy and progressed to other allergies later in life, a multi-state study found. In total, 13.4%

July 27, 2023

Newly discovered mechanism could revolutionize infertility care by promoting embryo implantation

A team from Kumamoto University has uncovered a new mechanism that could revolutionize infertility care by promoting embryo implantation.

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.